Eisai
Its AI model can predict the accumulation of amyloid-beta protein, a major Alzheimer's biomarker.
It will commence operations in 2024 by releasing a predictive algorithm for early dementia diagnosis.
It is the global multilingual version of the Japanese device NouKNOW.
With the creation of digital twins in studies, Unlearn generates an intelligent control arm that can reduce the sample size and decrease the number of participants given the placebo.